290 related articles for article (PubMed ID: 24562347)
1. Role of microRNAs in malignant mesothelioma.
Truini A; Coco S; Alama A; Genova C; Sini C; Dal Bello MG; Barletta G; Rijavec E; Burrafato G; Boccardo F; Grossi F
Cell Mol Life Sci; 2014 Aug; 71(15):2865-78. PubMed ID: 24562347
[TBL] [Abstract][Full Text] [Related]
2. Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma.
Martínez-Rivera V; Negrete-García MC; Ávila-Moreno F; Ortiz-Quintero B
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462963
[TBL] [Abstract][Full Text] [Related]
3. The role of microRNAs in the diagnosis and treatment of malignant pleural mesothelioma--a short review.
Sheff KW; Hoda MA; Dome B; Hegedus B; Klepetko W; Weiss GJ
Microrna; 2012; 1(1):40-8. PubMed ID: 25048089
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis.
Micolucci L; Akhtar MM; Olivieri F; Rippo MR; Procopio AD
Oncotarget; 2016 Sep; 7(36):58606-58637. PubMed ID: 27259231
[TBL] [Abstract][Full Text] [Related]
5. [microRNAs as biological indicators of environmental and occupational exposure to asbestos].
Minoia C; Sturchio E; Porro B; Ficociello B; Zambelli A; Imbriani M
G Ital Med Lav Ergon; 2011; 33(4):420-34. PubMed ID: 22452101
[TBL] [Abstract][Full Text] [Related]
6. Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma.
Gee GV; Koestler DC; Christensen BC; Sugarbaker DJ; Ugolini D; Ivaldi GP; Resnick MB; Houseman EA; Kelsey KT; Marsit CJ
Int J Cancer; 2010 Dec; 127(12):2859-69. PubMed ID: 21351265
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.
Busacca S; Germano S; De Cecco L; Rinaldi M; Comoglio F; Favero F; Murer B; Mutti L; Pierotti M; Gaudino G
Am J Respir Cell Mol Biol; 2010 Mar; 42(3):312-9. PubMed ID: 19502386
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs diagnostic and prognostic value as predictive markers for malignant mesothelioma.
Sturchio E; Berardinelli MG; Boccia P; Zanellato M; Gioiosa S
Arch Environ Occup Health; 2020; 75(8):471-482. PubMed ID: 32308151
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma.
Andersen M; Grauslund M; Ravn J; Sørensen JB; Andersen CB; Santoni-Rugiu E
J Mol Diagn; 2014 Jul; 16(4):418-30. PubMed ID: 24912849
[TBL] [Abstract][Full Text] [Related]
10. In Silico Transcriptomic Analysis of Wound-Healing-Associated Genes in Malignant Pleural Mesothelioma.
Rouka E; Beltsios E; Goundaroulis D; Vavougios GD; Solenov EI; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31212858
[No Abstract] [Full Text] [Related]
11. Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism.
De Santi C; Melaiu O; Bonotti A; Cascione L; Di Leva G; Foddis R; Cristaudo A; Lucchi M; Mora M; Truini A; Tironi A; Murer B; Boldorini R; Cipollini M; Gemignani F; Gasparini P; Mutti L; Landi S
Sci Rep; 2017 Jun; 7(1):3140. PubMed ID: 28600498
[TBL] [Abstract][Full Text] [Related]
12. Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trial.
Muti P; Sacconi A; Pulito C; Orlandi G; Donzelli S; Morrone A; Jiulian J; Cox GP; Kolb M; Pond G; Kavsak P; Levine MN; Blandino G; Strano S
J Exp Clin Cancer Res; 2022 Aug; 41(1):255. PubMed ID: 35987988
[TBL] [Abstract][Full Text] [Related]
13. Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets.
Ramírez-Salazar EG; Salinas-Silva LC; Vázquez-Manríquez ME; Gayosso-Gómez LV; Negrete-Garcia MC; Ramírez-Rodriguez SL; Chávez R; Zenteno E; Santillán P; Kelly-García J; Ortiz-Quintero B
Exp Mol Pathol; 2014 Dec; 97(3):375-85. PubMed ID: 25236577
[TBL] [Abstract][Full Text] [Related]
14. Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis.
Bruno R; Alì G; Giannini R; Proietti A; Lucchi M; Chella A; Melfi F; Mussi A; Fontanini G
Oncotarget; 2017 Jan; 8(2):2758-2770. PubMed ID: 27835874
[TBL] [Abstract][Full Text] [Related]
15. Non-coding RNA repertoires in malignant pleural mesothelioma.
Quinn L; Finn SP; Cuffe S; Gray SG
Lung Cancer; 2015 Dec; 90(3):417-26. PubMed ID: 26791801
[TBL] [Abstract][Full Text] [Related]
16. Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma.
Santarelli L; Staffolani S; Strafella E; Nocchi L; Manzella N; Grossi P; Bracci M; Pignotti E; Alleva R; Borghi B; Pompili C; Sabbatini A; Rubini C; Zuccatosta L; Bichisecchi E; Valentino M; Horwood K; Comar M; Bovenzi M; Dong LF; Neuzil J; Amati M; Tomasetti M
Lung Cancer; 2015 Dec; 90(3):457-64. PubMed ID: 26431916
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs dysregulation in human malignant pleural mesothelioma.
Balatti V; Maniero S; Ferracin M; Veronese A; Negrini M; Ferrocci G; Martini F; Tognon MG
J Thorac Oncol; 2011 May; 6(5):844-51. PubMed ID: 21358347
[TBL] [Abstract][Full Text] [Related]
18. Signal Transducer and Activator of Transcription 1 (STAT1) Knock-down Induces Apoptosis in Malignant Pleural Mesothelioma.
Arzt L; Halbwedl I; Gogg-Kamerer M; Popper HH
Pathol Oncol Res; 2017 Jul; 23(3):595-605. PubMed ID: 27987139
[TBL] [Abstract][Full Text] [Related]
19. microRNAs are differentially regulated between MDM2-positive and negative malignant pleural mesothelioma.
Walter RF; Vollbrecht C; Werner R; Wohlschlaeger J; Christoph DC; Schmid KW; Mairinger FD
Oncotarget; 2016 Apr; 7(14):18713-21. PubMed ID: 26918730
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant Mesothelioma.
Weber DG; Gawrych K; Casjens S; Brik A; Lehnert M; Taeger D; Pesch B; Kollmeier J; Bauer TT; Johnen G; Brüning T
Dis Markers; 2017; 2017():9280170. PubMed ID: 28321148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
